Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OmniAb, Inc. - Common Stock (NQ:OABI)

1.825 -0.025 (-1.35%)
Streaming Delayed Price Updated: 10:28 AM EDT, Aug 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 292,158
Open 1.710
Bid (Size) 1.820 (3)
Ask (Size) 1.830 (4)
Prev. Close 1.850
Today's Range 1.679 - 1.935
52wk Range 1.220 - 4.870
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OmniAb Announces $30 Million Private Placement
From OmniAb, Inc.
Via Business Wire
OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire

Performance

YTD
-47.9%
-47.9%
1 Month
-13.1%
-13.1%
3 Month
+37.2%
+37.2%
6 Month
-49.9%
-49.9%
1 Year
-58.3%
-58.3%

More News

Read More
Earnings Scheduled For August 6, 2025
Via Benzinga
OmniAb to Report Second Quarter 2025 Financial Results on August 6
From OmniAb, Inc.
Via Business Wire
Earnings Scheduled For May 8, 2025
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit
From OmniAb, Inc.
Via Business Wire
OmniAb Reports First Quarter 2025 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
OmniAb Introduces the xPloration® Partner Access Program
From OmniAb, Inc.
Via Business Wire
OmniAb to Participate in Five Upcoming Investor Conferences
From OmniAb, Inc.
Via Business Wire
OmniAb Announces Two New Appointments to its Board of Directors
From OmniAb, Inc.
Via Business Wire
OmniAb to Report First Quarter 2025 Financial Results on May 8
From OmniAb, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Surges Over 200 Points; US Crude Oil Inventories Increase More than Expected
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
Earnings Scheduled For March 18, 2025
Via Benzinga
OmniAb to Report Fourth Quarter 2024 Financial Results on March 18
From OmniAb, Inc.
Via Business Wire
OmniAb to Participate in Two Investor Conferences in March
From OmniAb, Inc.
Via Business Wire
OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference
From OmniAb, Inc.
Via Business Wire
OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
OmniAb to Participate in Two Investor Conferences in November
From OmniAb, Inc.
Via Business Wire
OmniAb to Report Third Quarter 2024 Financial Results on November 12
From OmniAb, Inc.
Via Business Wire
OmniAb to Participate in Two Investor Conferences in September
From OmniAb, Inc.
Via Business Wire
OABI Stock Earnings: OmniAb Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace

Frequently Asked Questions

Is OmniAb, Inc. - Common Stock publicly traded?
Yes, OmniAb, Inc. - Common Stock is publicly traded.
What exchange does OmniAb, Inc. - Common Stock trade on?
OmniAb, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for OmniAb, Inc. - Common Stock?
The ticker symbol for OmniAb, Inc. - Common Stock is OABI on the Nasdaq Stock Market
What is the current price of OmniAb, Inc. - Common Stock?
The current price of OmniAb, Inc. - Common Stock is 1.825
When was OmniAb, Inc. - Common Stock last traded?
The last trade of OmniAb, Inc. - Common Stock was at 08/25/25 10:28 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.